Claim OwnershipThe MTPConnect Podcast
Subscribed: 22Played: 1,046
Subscribe
© 2024 The MTPConnect Podcast
Description
The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.
174 Episodes
Reverse
Back in 2022, the Government of Western Australia issued a global challenge for a world-leading medical research and innovation solution to resolve a pressing problem of health service delivery in the remote Pilbara region.Ten projects were selected as finalists and given 12 months proof of concept funding to deliver their solution on the ground in the Pilbara. With the competition ending in October, the best solution will be selected to take home the $5 million prize supported by WA governme...
The Australian Stroke & Heart Research Accelerator (ASHRA) was established in early 2022 as part of the Targeted Translation Research Accelerator – a program delivered by MTPConnect for the Medical Research Future Fund.This is a research centre with a difference. Lead by Australia’s foremost heart and stroke researchers, ASHRA is aiming to transform the field of cardiovascular and stroke research in Australia by bringing a new sector-wide focus on clinical impact and entrepreneurship.ASHR...
Radiopharmaceuticals are precision nuclear medicines used for medical imaging and treatment that allow doctors to diagnose and deliver targeted therapies for diseases such as cancer. A new discussion paper from MTPConnect, ‘From Mines to Medicines. Australia’s Radiopharmaceuticals Future’ reveals how Australia is ready to play a leading role in the rise of the global radiopharmaceutical industry, as advanced therapies drive significant investment and rapid expansion. South Australia is i...
Perth- based biotech Argenica Therapeutics is developing therapies to treat stroke and other neurological conditions. A new neuroprotective peptide treatment is now being tested for ischaemic stroke patients presenting to emergency departments at 10 hospitals around Australia and is expected to improve patient outcomes by protecting the brain tissue from dying until blood flow can be restored. CEO and Managing Director Dr Liz Dallimore joins hosts Caroline Duell and WA Life Sciences Inno...
Innovators have told us that funding is important but difficult to navigate. The Australian Government is committed to investing billions of dollars into medical research and industry growth, cultivating a culture of translation and improving health for all Australians. So MTPConnect’s Adelaide Intermediary Program kicked off its first SA Insights event in 2024 by bringing the Commonwealth funders together to offer invaluable insights, advice, and inspiration to over 200 guests.This episode t...
MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program held its first annual Symposium in Sydney recently, bringing together all 11 companies from around Australia who are recipients of CTCM funding to develop new medical devices to improve health and wellbeing.In this episode, host Caroline Duell meets some of these Australian trailblazers - Eudaemon Technologies, CathRx, Ventora Medical, LBT Innovations, and 4DMedical, to find out more about their innovations and how...
The GSK Australia Graduate Researcher Program (GRP) is a 12-month work placement program for PhD graduates supported by MTPConnect's Researcher Exchange and Development within Industry (REDI) initiative showcasing opportunities in the pharmaceutical industry by providing hands-on experience for postdoctoral biomedical/science researchers.Since 2021, the GRP program has been opening doors for PhD science graduates and post-doctoral research academics who are interested in pursuing careers in t...
The GSK Australia Graduate Researcher Program (GRP) is a 12-month work placement program for PhD graduates supported by MTPConnect's Researcher Exchange and Development within Industry (REDI) initiative showcasing opportunities in the pharmaceutical industry by providing hands-on experience for postdoctoral biomedical/science researchers.Since 2021, the GRP program has been opening doors for PhD science graduates and post-doctoral research academics who are interested in pursuing careers in t...
As thousands in the medical technology sector headed to Anaheim, California for The MedTech 2023 Conference, MTPConnect was making sure that the 20 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections. In this podcast special from Los Angeles, our CEO Stuart Dignam was with the delegation when he caught up with US medtech movers and shakers to gain some insights into how to...
Dubbed the superbug pandemic, antimicrobial resistance (AMR) has been recognised by the World Health Organization as one of the top 10 public health threats facing humanity. Effective antibiotics underpin modern medicine and yet, it takes just two to three years for new antimicrobial medicines to become ineffective against superbugs. Worryingly, the innovation pipeline for new antibiotics is stagnating. An estimated 10 million people globally will die each year by 2050 from infectio...
Many well-known Australian medical innovations have been developed by visionary clinicians – doctors, nurses and allied health professionals – including the cochlear implant and spray on skin. In this special series we continue to explore how medical entrepreneurship can transform healthcare and meet Associate Professor Fiona Brownfoot, a specialist obstetrician and a clinician-scientist based in Melbourne.Fiona has co-founded healthtech start-up Kali Healthcare that is developing a new ...
Many well-known Australian medical innovations have been developed by visionary clinicians – doctors, nurses and allied health professionals – including the cochlear implant and spray on skin. In part 1 of this double episode, we explore medical entrepreneurship in Australia with Dr Brandon Carp, a Melbourne-based doctor who changed up his medical career to pursue his entrepreneurial business ideas in healthcare. Brandon has been involved in the Australian Clinical Entrepreneur Prog...
As Australia’s life sciences industry accelerator, MTPConnect’s is backing Australian medical devices of the future through the BioMedTech Horizons Program. It’s a $45 million initiative of the Medical Research Future Fund to bring life-saving medical products from an idea to patients. It’s about nurturing medtech companies through the first valley of death and de-risking product development to increase the appeal to private investment. The first phase of the program supported 11 c...
As Australia’s life sciences industry accelerator, MTPConnect’s is backing Australian medical devices of the future through the BioMedTech Horizons Program. It’s a $45 million initiative of the Medical Research Future Fund to bring life-saving medical products from an idea to patients. It’s about nurturing medtech companies through the first valley of death and de-risking product development to increase the appeal to private investment. The first phase of the program supported 11 c...
MTPConnect’s REDI Fellowships are improving engagement between researchers and industry and providing fellows with real-world innovation experiences within commercial industry settings. The idea of connecting researchers with industry is critical for the growth of Australia’s medical products sector and so far, 49 Fellows have been selected for industry placements, some with multinational companies, spearheading global collaborations and connections. One of those Fellows is Mark Tay...
After the international BIO 2023 convention wrapped up with Team Australia, MTPConnect took a tour of global biopharmaceutical company Sanofi’s mRNA Centre of Excellence located in Greater Boston and learnt more about the company’s plans for the Translational Science Hub being set up in Queensland in partnership with the Queensland Government, Griffith University, the University of Queensland. We catch up with Sanofi’s Chief Technology Officer and Global Head of Research and Biomarkers a...
We take you to MTPConnect’s inaugural seminar on 'Australian Women in Life Sciences Leadership - a Global Perspective' held during BIO 2023 in Boston. Founders, CEOs, board executives and managers gathered to discuss the opportunities and challenges faced by women in the biotech industry in a changing global market.The seminar, supported by Sanofi, showcased inspiring stories, insights and advice from trailblazing leaders and we caught up with two of the guest speakers, Dr Iris Depaz fro...
Back in June, MTPConnect joined the Australian delegation at BIO in Boston and organised several activities to showcase Australia’s fast-growing life sciences sector to the international biotech industry.With a powerful #TeamAustralia focus and a 430-strong delegation from Australia, BIO2023 was literally the biggest and best to date with over 20,000 attendees from 73 countries.In part one of this BIO episode, host Caroline Duell heads to the Australian Pavilion at the Boston Convention Centr...
Vexev founders, Dr John Carroll and Dr Eamonn Colley met in Sydney as PhD students interested in fluid dynamics. They have turned their talents to investigate blood flows to try and predict vascular disease.They have created an ultrasound-powered imaging robot and software platform — to automatically take fast and consistent 3D scans, to supercharge the diagnostic power of vascular clinicians, with the simple push of a button.The company has secured funding through Blackbird Ventures and are ...
ARIA Research is a Sydney-based start-up developing technologies delivering a sense of vision via sound (echolocation) to people who are blind or have low vision. The company’s defining advantage has been its diverse and inclusive team, which incorporates employees and end users living with blindness into every aspect of the project and organisation. Their breakthrough bionic vision system was funded initially through MTPConnect’s BioMedTech Horizons program (see podcast episode 124) and...
Comments
Download from Google Play
Download from App Store
United States